{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:30:23Z","timestamp":1789705823688,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud y Familias, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012514","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red-Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n","doi-asserted-by":"publisher","award":["FIS CP12\/03299"],"award-info":[{"award-number":["FIS CP12\/03299"]}],"id":[{"id":"10.13039\/501100012514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jacl.2017.02.001","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T15:30:24Z","timestamp":1487777424000},"page":"551-561.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia"],"prefix":"10.1016","volume":"11","author":[{"given":"Antonio J.","family":"Amor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Pinyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Sol\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Catalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Cof\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Herreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Amig\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Gilabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleix","family":"Sala-Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jacl.2017.02.001_bib1","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.jacl.2017.02.001_bib2","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jacl.2017.02.001_bib3","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3748\/wjg.v13.i10.1579","article-title":"Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease","volume":"13","author":"Hamaguchi","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.jacl.2017.02.001_bib4","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"issue":"14","key":"10.1016\/j.jacl.2017.02.001_bib5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jacl.2017.02.001_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2013.10.030","article-title":"Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology","volume":"232","author":"Loria","year":"2014","journal-title":"Atherosclerosis"},{"issue":"19","key":"10.1016\/j.jacl.2017.02.001_bib7","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","article-title":"Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults","volume":"164","author":"Kim","year":"2004","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.jacl.2017.02.001_bib8","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2337\/dc06-0455","article-title":"Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes","volume":"29","author":"Toledo","year":"2006","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jacl.2017.02.001_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","article-title":"Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis","volume":"227","author":"DeFilippis","year":"2013","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jacl.2017.02.001_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11892-008-0011-4","article-title":"Fatty liver, insulin resistance, and dyslipidemia","volume":"8","author":"Adiels","year":"2008","journal-title":"Curr Diab Rep"},{"issue":"4","key":"10.1016\/j.jacl.2017.02.001_bib11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0033-1358519","article-title":"Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease","volume":"33","author":"Cohen","year":"2013","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.jacl.2017.02.001_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2217\/clp.11.37","article-title":"Clinical applications of advanced lipoprotein testing in diabetes mellitus","volume":"6","author":"Moin","year":"2011","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.jacl.2017.02.001_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnmrs.2012.09.001","article-title":"Human serum\/plasma lipoprotein analysis by NMR: application to the study of diabetic dyslipidemia","volume":"70","author":"Mallol","year":"2013","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"issue":"7","key":"10.1016\/j.jacl.2017.02.001_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jacl.2017.02.001_bib15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jacl.2017.02.001_bib16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal","volume":"58","author":"Machado","year":"2013","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jacl.2017.02.001_bib17","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jacl.2017.02.001_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2016.02.023","article-title":"Fatty liver is an independent predictor of early carotid atherosclerosis","volume":"65","author":"Pais","year":"2016","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.jacl.2017.02.001_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.numecd.2015.04.009","article-title":"Prevalence by sex of preclinical carotid atherosclerosis in newly diagnosed type 2 diabetes","volume":"25","author":"Catalan","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.jacl.2017.02.001_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000346553","article-title":"Mediterranean diet adherence in individuals with prediabetes and unknown diabetes: the Di@bet.es Study","volume":"62","author":"Ortega","year":"2013","journal-title":"Ann Nutr Metab"},{"issue":"2","key":"10.1016\/j.jacl.2017.02.001_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2337\/dc11-1334","article-title":"Clinical usefulness of a new equation for estimating body fat","volume":"35","author":"G\u00f3mez-Ambrosi","year":"2012","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.jacl.2017.02.001_bib22","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","article-title":"Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism","volume":"26","author":"Ascaso","year":"2003","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jacl.2017.02.001_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","article-title":"Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)","volume":"16","author":"Balkau","year":"1999","journal-title":"Diabet Med"},{"issue":"Suppl 1","key":"10.1016\/j.jacl.2017.02.001_bib24","first-page":"S13","article-title":"2. Classification and diagnosis of diabetes","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jacl.2017.02.001_bib25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1194\/jlr.D050120","article-title":"Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy","volume":"56","author":"Mallol","year":"2015","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.jacl.2017.02.001_bib26","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00216-011-5705-9","article-title":"Particle size measurement of lipoprotein fractions using diffusion-ordered NMR spectroscopy","volume":"402","author":"Mallol","year":"2012","journal-title":"Anal Bioanal Chem"},{"issue":"4","key":"10.1016\/j.jacl.2017.02.001_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"issue":"3","key":"10.1016\/j.jacl.2017.02.001_bib28","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1373\/clinchem.2010.155333","article-title":"HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events","volume":"57","author":"Rosenson","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2017.02.001_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0065-3233(08)60641-5","article-title":"Apolipoprotein B and low-density lipoprotein structure: implications for biosynthesis of triglyceride-rich lipoproteins","volume":"45","author":"Schumaker","year":"1994","journal-title":"Adv Protein Chem"},{"key":"10.1016\/j.jacl.2017.02.001_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.jacl.2017.02.001_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1572-0241.2006.01041.x","article-title":"Nonalcoholic fatty liver disease in severely obese subjects","volume":"102","author":"Gholam","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jacl.2017.02.001_bib32","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2337\/dc07-1088","article-title":"Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state","volume":"30","author":"Cali","year":"2007","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jacl.2017.02.001_bib33","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jc.2015-3111","article-title":"Hepatic steatosis and insulin resistance, but not steatohepatitis, promote atherogenic dyslipidemia in NAFLD","volume":"101","author":"Bril","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jacl.2017.02.001_bib34","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2337\/dc16-0798","article-title":"Pioglitazone prevents diabetes in patients with insulin resistance and cerebrovascular disease","volume":"39","author":"Inzucchi","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jacl.2017.02.001_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M13-1725","article-title":"Prevention of diabetes with Mediterranean diets","volume":"160","author":"Salas-Salvad\u00f3","year":"2014","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jacl.2017.02.001_bib36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jacl.2017.02.001_bib37","first-page":"560","article-title":"Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations","volume":"11","author":"Younossi","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jacl.2017.02.001_bib38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2016.02.014","article-title":"Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis","volume":"247","author":"Amor","year":"2016","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.jacl.2017.02.001_bib39","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/CIRCULATIONAHA.108.816181","article-title":"Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women","volume":"119","author":"Mora","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacl.2017.02.001_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2337\/dc07-1558","article-title":"Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions","volume":"31","author":"Kantartzis","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2017.02.001_bib41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1476-511X-13-100","article-title":"Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile","volume":"13","author":"Corey","year":"2014","journal-title":"Lipids Health Dis"},{"issue":"11","key":"10.1016\/j.jacl.2017.02.001_bib42","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2337\/diabetes.53.11.2893","article-title":"Hepatic lipase mRNA, protein, and plasma enzyme activity is increased in the insulin-resistant, fructose-fed Syrian golden hamster and is partially normalized by the insulin sensitizer rosiglitazone","volume":"53","author":"Lewis","year":"2004","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.jacl.2017.02.001_bib43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/dmrr.2312","article-title":"Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance","volume":"28","author":"Miksztowicz","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10.1016\/j.jacl.2017.02.001_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.108.178756","article-title":"Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia","volume":"103","author":"Xiao","year":"2008","journal-title":"Circ Res"},{"issue":"15","key":"10.1016\/j.jacl.2017.02.001_bib45","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1161\/01.CIR.99.15.1959","article-title":"Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density","volume":"99","author":"Zambon","year":"1999","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacl.2017.02.001_bib46","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2006.09.043","article-title":"Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study","volume":"49","author":"El Harchaoui","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacl.2017.02.001_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MOL.0000000000000067","article-title":"The composition and metabolism of large and small LDL","volume":"25","author":"Diffenderfer","year":"2014","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"10.1016\/j.jacl.2017.02.001_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2006.05.007","article-title":"LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"192","author":"Mora","year":"2007","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.jacl.2017.02.001_bib49","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2012.03.060","article-title":"High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis)","volume":"60","author":"Mackey","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacl.2017.02.001_bib50","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/ATVBAHA.114.304349","article-title":"Use of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart Association\/American College of Cardiology Guidelines: the Multi-Ethnic Study of Atherosclerosis","volume":"35","author":"Steffen","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2017.02.001_bib51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2016.09.009","article-title":"Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes","volume":"254","author":"Afarideh","year":"2016","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.jacl.2017.02.001_bib52","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/hep.23789","article-title":"Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical\u00a0perspective of prospective data","volume":"52","author":"Ghouri","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jacl.2017.02.001_bib53","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2014.10.002","article-title":"National Lipid Association Annual Summary of Clinical Lipidology 2015","volume":"8","author":"Bays","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.jacl.2017.02.001_bib54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4158\/EP151126.CS","article-title":"Consensus statement by the American Association of Clinical Endocrinologists and American College Of Endocrinology on the comprehensive type 2 diabetes management algorithm \u2013 2016 Executive Summary","volume":"22","author":"Garber","year":"2016","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.jacl.2017.02.001_bib55","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cgh.2014.10.008","article-title":"Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile","volume":"13","author":"Siddiqui","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jacl.2017.02.001_bib56","doi-asserted-by":"crossref","first-page":"e115403","DOI":"10.1371\/journal.pone.0115403","article-title":"LDL-Migration Index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study","volume":"9","author":"Imajo","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jacl.2017.02.001_bib57","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2337\/diabetes.52.3.803","article-title":"Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome","volume":"52","author":"Watts","year":"2003","journal-title":"Diabetes"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287417300272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287417300272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:22:27Z","timestamp":1658103747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287417300272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1933287417300272"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2017.02.001","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2017.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}